檢索結果 - Manish R. Patel

Refine Results
  1. 1
    Recurrent pleural effusions and cardiac tamponade as possible manifestations of pseudoprogression associated with nivolumab therapy– a report of two cases

    Recurrent pleural effusions and cardiac tamponade as possible manifestations of pseudoprogression associated with nivolumab therapy– a report of two cases 由 Bhaskar Kolla, Manish R. Patel

    出版 2016
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    A phase 2 trial of trifluridine/tipiracil plus nivolumab in patients with heavily pretreated microsatellite‐stable metastatic colorectal cancer

    A phase 2 trial of trifluridine/tipiracil plus nivolumab in patients with heavily pretreated microsatellite‐stable metastatic colorectal cancer 由 Manish R. Patel, Gerald S. Falchook, K Hamada, Lukas Makris, Johanna C. Bendell

    出版 2021
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    Combination trial of duvelisib (IPI‐145) with rituximab or bendamustine/rituximab in patients with non‐Hodgkin lymphoma or chronic lymphocytic leukemia

    Combination trial of duvelisib (IPI‐145) with rituximab or bendamustine/rituximab in patients with non‐Hodgkin lymphoma or chronic lymphocytic leukemia 由 Ian W. Flinn, Mohamad Cherry, Michael B. Maris, Jeffrey Matous, Jesús G. Berdeja, Manish R. Patel

    出版 2019
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    Fluorescent Fructose Derivatives for Imaging Breast Cancer Cells

    Fluorescent Fructose Derivatives for Imaging Breast Cancer Cells 由 Jelena Levi, Zhen Cheng, Olivier Gheysens, Manish R. Patel, Carmel T. Chan, Yingbing Wang, Mohammad Namavari, Sanjiv S. Gambhir

    出版 2007
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    Vitamin D intake to attain a desired serum 25-hydroxyvitamin D concentration

    Vitamin D intake to attain a desired serum 25-hydroxyvitamin D concentration 由 John F. Aloia, Manish R. Patel, Rhett DiMaano, Melissa Li‐Ng, Sonia A Talwar, Mageda Mikhail, Simcha Pollack, James K. Yeh

    出版 2008
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    Phase I study of the investigational oral mTORC1/2 inhibitor sapanisertib (TAK-228): tolerability and food effects of a milled formulation in patients with advanced solid tumours

    Phase I study of the investigational oral mTORC1/2 inhibitor sapanisertib (TAK-228): tolerability and food effects of a milled formulation in patients with advanced solid tumours 由 Kathleen N. Moore, Todd M. Bauer, Gerald S. Falchook, Swapan K. Chowdhury, Chirag Patel, Rachel Neuwirth, Aaron Enke, Fabian Zohren, Manish R. Patel

    出版 2018
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    CUDC-907 in relapsed/refractory diffuse large B-cell lymphoma, including patients with MYC-alterations: results from an expanded phase I trial

    CUDC-907 in relapsed/refractory diffuse large B-cell lymphoma, including patients with MYC-alterations: results from an expanded phase I trial 由 Yasuhiro Oki, Kevin R. Kelly, Ian W. Flinn, Manish R. Patel, Robert Gharavi, Anna Ma, Jefferson Parker, Amir Hafeez, David Tuck, Anas Younes

    出版 2017
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    Hospital‐based surveillance of intussusception among infants

    Hospital‐based surveillance of intussusception among infants 由 Eder Gatti Fernandes, Eyal Leshem, Manish R. Patel, Brendan Flannery, Alessandra Cristina Guedes Pellini, Maria Amélia de Sousa Mascena Veras, Helena Keico Sato

    出版 2016
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    Phase 1 study of oral TAS-102 in patients with refractory metastatic colorectal cancer

    Phase 1 study of oral TAS-102 in patients with refractory metastatic colorectal cancer 由 Johanna C. Bendell, Lee S. Rosen, Robert J. Mayer, Jonathan W. Goldman, Jeffrey R. Infante, Fabio Benedetti, Donghu Lin, Hirokazu Mizuguchi, C. Zergebel, Manish R. Patel

    出版 2015
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    Nutrition Status and Health‐Related Quality of Life Among Outpatients With Advanced Head and Neck Cancer

    Nutrition Status and Health‐Related Quality of Life Among Outpatients With Advanced Head and Neck Cancer 由 Urvashi Mulasi, David M. Vock, Harriët Jager‐Wittenaar, Levi Teigen, Adam J. Kuchnia, Gautam Jha, Naomi Fujioka, Venkatesh K. Rudrapatna, Manish R. Patel, Carrie P. Earthman

    出版 2020
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  11. 11
    Neoadjuvant GTX Chemotherapy and IMRT‐based chemoradiation for borderline resectable pancreatic cancer

    Neoadjuvant GTX Chemotherapy and IMRT‐based chemoradiation for borderline resectable pancreatic cancer 由 Manish R. Patel, Sarah E. Hoffe, Mokenge P. Malafa, Pamela J. Hodul, Jason Klapman, Barbara A. Centeno, Jongphil Kim, James F. Helm, Tiffany Valone, Gregory M. Springett

    出版 2011
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    The MDM2–p53 Antagonist Brigimadlin (BI 907828) in Patients with Advanced or Metastatic Solid Tumors: Results of a Phase Ia, First-in-Human, Dose-Escalation Study

    The MDM2–p53 Antagonist Brigimadlin (BI 907828) in Patients with Advanced or Metastatic Solid Tumors: Results of a Phase Ia, First-in-Human, Dose-Escalation Study 由 Patricia LoRusso, Noboru Yamamoto, Manish R. Patel, Scott A. Laurie, Todd M. Bauer, Junxian Geng, Teffany Davenport, Michael Teufel, Jian Li, Mehdi Lahmar, Mrinal M. Gounder

    出版 2023
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  13. 13
    Safety profile of avelumab in patients with advanced solid tumors: A pooled analysis of data from the phase 1 JAVELIN solid tumor and phase 2 JAVELIN Merkel 200 clinical trials

    Safety profile of avelumab in patients with advanced solid tumors: A pooled analysis of data from the phase 1 JAVELIN solid tumor and phase 2 JAVELIN Merkel 200 clinical trials 由 Karen Kelly, Jeffrey R. Infante, Matthew H. Taylor, Manish R. Patel, Deborah J. Wong, Nicholas Iannotti, Janice M. Mehnert, Anja H. Loos, Helga Koch, Isabell Speit, James L. Gulley

    出版 2018
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    Phase I study of imalumab (BAX69), a fully human recombinant antioxidized macrophage migration inhibitory factor antibody in advanced solid tumours

    Phase I study of imalumab (BAX69), a fully human recombinant antioxidized macrophage migration inhibitory factor antibody in advanced solid tumours 由 Devalingam Mahalingam, Manish R. Patel, Jasgit C. Sachdev, Lowell L. Hart, Niels Halama, Ramesh K. Ramanathan, John Sarantopoulos, Dirk Völkel, Ashraf Youssef, Floris A. de Jong, Apostolia M. Tsimberidou

    出版 2020
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    First-in-Human, Phase 1 Dose-Escalation Study of Biparatopic Anti-HER2 Antibody–Drug Conjugate MEDI4276 in Patients with HER2-positive Advanced Breast or Gastric Cancer

    First-in-Human, Phase 1 Dose-Escalation Study of Biparatopic Anti-HER2 Antibody–Drug Conjugate MEDI4276 in Patients with HER2-positive Advanced Breast or Gastric Cancer 由 Mark D. Pegram, Erika Hamilton, Antoinette R. Tan, Anna Maria Storniolo, Kemal Balic, Anton I. Rosenbaum, Meina Liang, Peng He, Shannon Marshall, Anita Scheuber, Mayukh Das, Manish R. Patel

    出版 2021
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    A Phase I/Ib Study of Enzalutamide Alone and in Combination with Endocrine Therapies in Women with Advanced Breast Cancer

    A Phase I/Ib Study of Enzalutamide Alone and in Combination with Endocrine Therapies in Women with Advanced Breast Cancer 由 Lee S. Schwartzberg, Denise A. Yardley, Anthony Elias, Manish R. Patel, Patricia LoRusso, Howard A. Burris, Ayca Gucalp, Amy Peterson, Martha Blaney, Joyce Steinberg, Jacqueline A. Gibbons, Tiffany A. Traina

    出版 2017
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    A First-in-Human Study of the New Oral Selective Estrogen Receptor Degrader AZD9496 for ER+/HER2− Advanced Breast Cancer

    A First-in-Human Study of the New Oral Selective Estrogen Receptor Degrader AZD9496 for ER+/HER2− Advanced Breast Cancer 由 Erika Hamilton, Manish R. Patel, Anne Armstrong, Richard D. Baird, Komal Jhaveri, Matthias Hoch, Teresa Klinowska, Justin P.O. Lindemann, Shethah Morgan, Gaia Schiavon, Hazel M. Weir, Seock‐Ah Im

    出版 2018
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  18. 18
    Pharmacokinetic Study of Rucaparib in Patients With Advanced Solid Tumors

    Pharmacokinetic Study of Rucaparib in Patients With Advanced Solid Tumors 由 Geoffrey I. Shapiro, Rebecca Kristeleit, Howard A. Burris, Patricia LoRusso, Manish R. Patel, Yvette Drew, Heidi Giordano, Lara Maloney, Simon P. Watkins, Sandra Goble, Sarah Jaw‐Tsai, Jim Xiao

    出版 2018
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  19. 19
    a Phase 1 Evaluation of Duvelisib (IPI-145), a PI3K-δ,γ Inhibitor, in Patients with Relapsed/Refractory iNHL

    a Phase 1 Evaluation of Duvelisib (IPI-145), a PI3K-δ,γ Inhibitor, in Patients with Relapsed/Refractory iNHL 由 Ian W. Flinn, Yasuhiro Oki, Manish R. Patel, Steven M. Horwitz, Francine M. Foss, Jennifer Sweeney, Kerstin Allen, Mark Douglas, Lori Steelman, Joi Dunbar, Howard M. Stern, Patrick Kelly, Brad S. Kahl

    出版 2014
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  20. 20
    Avelumab in patients with previously treated metastatic melanoma: phase 1b results from the JAVELIN Solid Tumor trial

    Avelumab in patients with previously treated metastatic melanoma: phase 1b results from the JAVELIN Solid Tumor trial 由 Ulrich Keilholz, Janice M. Mehnert, Sebastian Bauer, Hugues Bourgeois, Manish R. Patel, Donald Gravenor, John Nemunaitis, Matthew H. Taylor, Lucjan Wyrwicz, Keun‐Wook Lee, Vijay Kasturi, Kevin M. Chin, Anja von Heydebreck, James L. Gulley

    出版 2019
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: